Budesonid 1mg/2ml

Suspension for Nebuliser

Pulmicort Respules contain the potent, non-halogenated, corticosteroid, budesonide,
for use in bronchial asthma, in patients where use of a pressurised inhaler or dry
powder formulation is unsatisfactory or inappropriate.
Pulmicort Respules are also recommended for use in infants and children with croup
(acute viral upper respiratory tract infection also known as viral
laryngotracheobronchitis or laryngitis subglottica), in which hospitalisation is
indicated.

Posology
The dosage of Pulmicort Respules should be adjusted to the need of the
individual.
Dosage schedules: The dose delivered to the patient varies depending on
the nebulising equipment used. The nebulisation time and the dose
delivered is dependent on flow rate, volume of nebuliser chamber and fill
volume. An air-flow rate of 6 - 8 litres per minute through the device
should be employed. A suitable fill volume for most nebulisers is 2 - 4 ml.
The dosage of Pulmicort Respules should be adjusted to the need of the
individual. The dose should be reduced to the minimum needed to maintain
good asthma control. The highest dose (2 mg per day) for children under 12
years should only be considered in children with severe asthma and during
limited periods.
Bronchial asthma
Initiation of therapy
When treatment is started, during periods of severe asthma and while
reducing or discontinuing oral glucocorticosteroids, the recommended dose
of Pulmicort Respules is:
Adults (including the elderly): Usually 1 – 2 mg twice daily. In very severe
cases the dosage may be further increased.
Paediatric population
Children 12 years and older: Dosage as for adults.
Children 3 months to 12 years: 0.5 – 1 mg twice daily.
Maintenance
The maintenance dose should be individualised and be the lowest dose
which keeps the patient symptom-free.
Adults (including the elderly and children 12 years and older): 0.5 - 1 mg
twice daily.
Paediatric population
Children 3 months to 12 years: 0.25 - 0.5 mg twice daily.